A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer

Clinical trial NCT02054338 · TERMINATED

Trial details

NCT number: NCT02054338
Sponsor: Pierre Fabre Medicament
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2006-06-01
Primary completion: 2011-06-01
Enrollment: 1004

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.